Adaptive Autism Intervention for Toddlers with Autism
(CAIT Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a program to help toddlers with autism improve their social and communication skills. The program starts with play-based activities and is adjusted based on each child's progress. These activities have been shown to improve social communication in young children with autism. The goal is to find the best way to support these children in everyday settings.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on behavioral interventions for toddlers with autism.
What data supports the idea that Adaptive Autism Intervention for Toddlers with Autism is an effective treatment?
The available research shows that Adaptive Autism Intervention for Toddlers with Autism, such as JASPER, is effective in improving language and play skills in young children with autism. One study found that children who received joint attention and play interventions showed greater improvements in language skills compared to those who did not receive these interventions. Another study demonstrated that teachers could successfully implement these interventions in classrooms, leading to significant improvements in joint attention and play skills. Additionally, a pilot study showed that minimally verbal children with autism who received JASPER treatment had more diverse play and better engagement in the classroom. These findings suggest that this treatment can effectively enhance important developmental skills in children with autism.12345
What safety data exists for the Adaptive Autism Intervention for Toddlers with Autism?
The studies provided do not directly address safety data for the intervention. However, they suggest that interventions like JASPER, which focus on joint attention and play, are beneficial and can be implemented in various settings (classroom, parent-mediated) without reported adverse effects. These interventions have shown improvements in joint attention, play skills, and language outcomes in young children with autism, indicating they are generally well-tolerated and effective.13456
Is JASPER a promising treatment for toddlers with autism?
Yes, JASPER is a promising treatment for toddlers with autism. It helps improve important skills like joint attention and play, which are crucial for social interaction and communication. Studies show that children who receive JASPER make significant progress in these areas, and even brief sessions can lead to noticeable improvements.14567
Research Team
Eligibility Criteria
This trial is for toddlers aged 2-3 with autism spectrum disorder (ASD) who are receiving early intervention in East Harlem and the Bronx, NY. They must have a clinical ASD diagnosis or ADOS-2 confirmation, and their caregivers must consent to learn intervention strategies if required. Children with co-morbid disorders like cerebral palsy or Down syndrome cannot participate.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- jasPEER (Behavioural Intervention)
- JASPER (Behavioural Intervention)
- JASPER Plus+ (Behavioural Intervention)
- Structured Teaching (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor
Dr. Thomas Rando
University of California, Los Angeles
Chief Medical Officer since 2023
MD from UCLA
Amir Naiberg
University of California, Los Angeles
Chief Executive Officer since 2024
JD from UCLA
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University